Marc Jacquemin, MD

PhD
Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium

Prof. Dr. Marc Jacquemin is responsible for the Hemostasis Laboratory of the University Hospitals Gasthuisberg in Leuven. He is also carrying out research in the Center for Molecular and Vascular Biology in KULeuven. He obtained his medical degree and specialised in Clinical Biology at the Catholic University of Louvain, Belgium. He also obtained his PhD at the Catholic University of Louvain for his work on human monoclonal anti-Factor VIII antibodies. His research is focused on treatment of inhibitors in hemophilia A patients and on the mechanisms regulating FVIII activity.

Presentation(s):

• PB0098 - Long-term persistence of anti-PF4-antibodies following Vaccine-Induced Thrombotic Thrombocytopenia after first ChAdOx1 vaccination.

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0666 - A new FVIII chromogenic assay with bovine FX is sensitive enough for the diagnosis of severe haemophilia A.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• OC 57.4 - Decreased DNase activity in severe COVID-19 correlates with increased circulating NET burden

  Tuesday, July 12, 2022
  11:30 AM – 11:45 AM

• PB1063 - A sensitive and user-friendly method for quantifying VWF collagen binding (VWF:CB) using a fiber optic - surface plasmon resonance biosensor

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1111 - A novel prothrombin R533Q variant in patient with recurrent venous thrombosis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1290 - The contribution of peptidylarginine deiminase 4 and NETs to a dysregulated VWF/ADAMTS13 axis in Staphylococcus aureus bacteremia in patients

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM